Bipolar Disorder Trial, Recruiting NCT07127913 Sponsor: Andrew Krystal Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT07127913
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 22 and 70 years old
  • You have been diagnosed with Bipolar II Disorder and have been experiencing a depressive episode lasting at least 1 year that has not responded to treatments
  • You have not had a manic or hypomanic (elevated mood) episode in the last 2 years
  • You are currently taking a mood-stabilizing or antipsychotic medication at a stable dose for at least 2 weeks, and are willing to continue taking it throughout the study
  • You have either tried electroconvulsive therapy (ECT/shock therapy) but couldn't tolerate or sustain it, were unable to complete it due to side effects, or were advised to have ECT but were unwilling or unable to receive it
  • You score above 26 on a standard depression rating scale at two separate check-in visits (confirm with trial site)
  • Your psychiatric medication has not changed in the 4 weeks before joining and is not expected to change during the study
  • You are willing and able to take part in a study involving brain recording and stimulation (an invasive procedure)
  • You are willing and able to attend multiple research visits and follow a research routine at home
  • You are willing and able to give your informed consent to participate
  • You can speak and read English

Who may not be able to join:

  • You have a diagnosis of a psychotic disorder, eating disorder, panic disorder, PTSD, OCD, tic disorder, or another significant psychiatric condition beyond depression or generalized anxiety disorder
  • Your main current diagnosis is generalized anxiety disorder rather than depression
  • You are currently having thoughts of suicide with a specific plan and intent
  • You have been hospitalized due to a suicide attempt in the last 2 years
  • You have had problems with alcohol or substance misuse (other than caffeine) in the last 6 months
  • You have a personality disorder that the study team believes could affect your safety or ability to follow the study rules
  • You have fibromyalgia or chronic fatigue syndrome
  • You currently need to take strong prescription pain medications (narcotics) on an ongoing basis
  • You have a history of traumatic brain injury, a neurological condition, or a developmental delay
  • You have a history of seizures
  • You have had a brain MRI within the last year that showed significant abnormalities
  • You have previously had brain surgery to remove or destroy tissue, or currently have a deep brain stimulation device or other brain stimulation implant
  • You have any implanted medical device that is not compatible with MRI or with this study's equipment
  • You have serious medical conditions that increase the risk of surgery, such as severe diabetes, major organ failure, history of bleeding stroke, need for blood thinners (other than aspirin), active infection, certain brain or heart conditions, a weakened immune system, or a cancer diagnosis with a life expectancy of less than 5 years (confirm with trial site for full list)
  • You are unable to safely stop blood-thinning or anti-clotting medications for surgery (you would need to discuss this with your doctor and the study team)
  • You have a blood clotting disorder, unless you have been reviewed and cleared by a blood specialist
  • You have known allergies or sensitivities to materials used in the study device, including titanium, polyurethane, silicone, or stainless steel
  • You live alone with no one available to support you after leaving the hospital
  • You are unable to attend the required follow-up visits during the study

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andrew Krystal, MD, MS, University of California, San Francisco

Phone: 510-621-3193

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Andrew Krystal
Registry
ClinicalTrials.gov
Start date
16 July 2025
Est. completion
28 June 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in Montgomery-Asberg Depression Rating Scale (MADRS) score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov